Search - tctmd.com

Displaying 421 - 440 of 607

Sort: Relevancy | Date

News Daily News

Study Suggests Immature Platelet Count Predicts MACE Risk in CAD

November 17, 2014

News Daily News

Restenosis at Routine Angiographic Follow-up Predicts Long-term Mortality After PCI

L.A. McKeown

October 24, 2014

News Daily News

研究探索了在氯吡格雷治疗的PCI患者中，糖尿病对血小板反应性的影响

October 10, 2014

News Daily News

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

October 10, 2014

News Daily News

Registry Study: Survival Benefit for Treating CTO After Primary PCI

Todd Neale

October 10, 2014

News Daily News

Estudios Exploran el Impacto de la Diabetes sobre la Reactividad Plaquetaria en Pacientes PCI a Tratamiento con Clopodogrel

October 10, 2014

News Daily News

大多数稳定CAD患者误解了PCI的目的

L.A. McKeown

October 03, 2014

News Daily News

Registro del CORONOR: Warfarin a Largo Plazo + Agente Antiplaquetario Aumenta las Hemorragias en Pacientes con EAC Estable

L.A. McKeown

October 03, 2014

News Daily News

Majority of Stable CAD Patients Misunderstand Purpose of PCI

L.A. McKeown

October 03, 2014

News Daily News

La Inmensa Mayoría de Pacientes con EAC Estable No Entienden el Propósito de una PCI

L.A. McKeown

October 03, 2014

News Daily News

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

Caitlin E. Cox

October 03, 2014

News Daily News

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

L.A. McKeown

October 03, 2014

Presentation

Variation in Patients’ Perceptions of ElectivePCI in Stable Coronary Artery Disease

Presenter: Faraz Kureshi

September 26, 2014

News Industry News

New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents

September 16, 2014

News Industry News

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

September 16, 2014

News Industry News

St. Jude Medical Announces Launch of OPTIS Integrated System

September 15, 2014

News Conference News TCT 2014

Keynote Address Focuses on Newer DES, Problematic Subgroups

September 15, 2014

News Industry News

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

September 15, 2014

News Industry News

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 14, 2014

News Daily News

Nonclinical Factors Substantially Affect Detection of Obstructive CAD

Yael L. Maxwell

September 13, 2014

Advertisement

Study Suggests Immature Platelet Count Predicts MACE Risk in CAD

Restenosis at Routine Angiographic Follow-up Predicts Long-term Mortality After PCI

研究探索了在氯吡格雷治疗的PCI患者中，糖尿病对血小板反应性的影响

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

Registry Study: Survival Benefit for Treating CTO After Primary PCI

Estudios Exploran el Impacto de la Diabetes sobre la Reactividad Plaquetaria en Pacientes PCI a Tratamiento con Clopodogrel

大多数稳定CAD患者误解了PCI的目的

Registro del CORONOR: Warfarin a Largo Plazo + Agente Antiplaquetario Aumenta las Hemorragias en Pacientes con EAC Estable

Majority of Stable CAD Patients Misunderstand Purpose of PCI

La Inmensa Mayoría de Pacientes con EAC Estable No Entienden el Propósito de una PCI

Ischemia Testing Foretells Prognosis in Diabetic Patients with Asymptomatic CAD

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

Variation in Patients’ Perceptions of ElectivePCI in Stable Coronary Artery Disease

New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents

Micell Technologies Highlights Positive Three-Year Data from MiStent SES DESSOLVE Clinical Studies at TCT 2014

St. Jude Medical Announces Launch of OPTIS Integrated System

Keynote Address Focuses on Newer DES, Problematic Subgroups

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

Nonclinical Factors Substantially Affect Detection of Obstructive CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content